Antti Ylipää

发表

A systems biological approach to identify key transcription factors and their genomic neighborhoods in human sarcomas

M. Nykter, Wei Zhang, O. Yli-Harja, 2011, Chinese journal of cancer.

High-throughput identification of DNA copy number aberrations

Antti Ylipää, 2008 .

Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor

Jilong Yang, Antti Ylipää, Xiaoling Du, 2013, Journal of Hematology & Oncology.

An Integrated Study of Aberrant Gene Copy Number and Gene Expression in GIST and LMS

M. Nykter, K. Hunt, I. Shmulevich, 2010, Technology in cancer research & treatment.

Myeloid cell expressed proprotein convertase FURIN attenuates inflammation

M. Nykter, M. Pesu, Antti Ylipää, 2016, Oncotarget.

Discrete stochastic simulation of cell signaling: comparison of computational tools

M.-L. Linne, T. Manninen, A. Pettinen, 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

Characterization of aberrant pathways across human cancers

Olli Yli-Harja, Matti Nykter, Wei Zhang, 2013, BMC Systems Biology.

Transcriptome Sequencing Reveals PCAT5 as a Novel ERG-Regulated Long Noncoding RNA in Prostate Cancer.

Wei Zhang, Leena Latonen, Matti Nykter, 2015, Cancer research.

Genetic aberrations in soft tissue leiomyosarcoma.

K. Hunt, Wei Zhang, A. Lazar, 2009, Cancer letters.

Integrative genomic characterization and a genomic staging system for gastrointestinal stromal tumors

M. Nykter, K. Hunt, Wei Zhang, 2011, Cancer.

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer.

M. Nykter, L. Latonen, P. Ruusuvuori, 2015 .

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

Wei Zhang, M. Nykter, L. Latonen, 2015, Oncotarget.

Construction of therapeutically relevant human prostate epithelial fate map by utilising miRNA and mRNA microarray expression data

M. Nykter, T. Visakorpi, N. Maitland, 2015, British Journal of Cancer.

MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.

M. Nykter, T. Visakorpi, N. Maitland, 2015, European urology.

Genomic amplification and high expression of EGFR are key targetable oncogenic events in malignant peripheral nerve sheath tumor

Jilong Yang, Antti Ylipää, Xiaoling Du, 2013, Journal of Hematology & Oncology.

Genomic and Molecular Characterization of Malignant Peripheral Nerve Sheath Tumor Identifies the IGF1R Pathway as a Primary Target for Treatment

Wei Zhang, M. Nykter, D. Lev, 2011, Clinical Cancer Research.

Cancer systems biology: signal processing for cancer research

Olli Yli-Harja, Matti Nykter, Wei Zhang, 2011, Chinese journal of cancer.

High Density of NRF2 Expression in Malignant Cells Is Associated with Increased Risk of CNS Metastasis in Early-Stage NSCLC

S. Ekman, Antti Ylipää, P. Micke, 2021, Cancers.

Abstract 5198: Elucidation of dynamic prostate epithelial hierarchy: Insights into transcriptional and epigenetic regulatory mechanisms

T. Visakorpi, N. Maitland, Antti Ylipää, 2012 .

Finding common aberrations in array CGH data

O. Yli-Harja, Wei Zhang, A. Ylipaa, 2008, 2008 3rd International Symposium on Communications, Control and Signal Processing.

MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.

M. Nykter, T. Visakorpi, N. Maitland, 2015, European urology.

Recurrent SKIL-activating rearrangements in ETS-negative prostate cancer

Wei Zhang, M. Nykter, P. Ruusuvuori, 2015, Oncotarget.